ČEŠKOVÁ, Eva, Radovan PŘIKRYL, Tomáš KAŠPÁREK and Marta ONDRUŠOVÁ. Prolactin levels in risperidone treatment of first episode schizophrenia. International Journal of Psychiatry in Clinical Practice. vol. 2003, No 8, p. 1-6. ISSN 1365-1501. 2003.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Prolactin levels in risperidone treatment of first episode schizophrenia.
Name (in English) Prolactin levels in risperidone treatment of first episode schizophrenia.
Authors ČEŠKOVÁ, Eva (203 Czech Republic, guarantor), Radovan PŘIKRYL (203 Czech Republic), Tomáš KAŠPÁREK (203 Czech Republic) and Marta ONDRUŠOVÁ (203 Czech Republic).
Edition International Journal of Psychiatry in Clinical Practice, 2003, 1365-1501.
Other information
Original language Czech
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 0.191
RIV identification code RIV/00216224:14110/03:00021237
Organization unit Faculty of Medicine
UT WoS 000220242100006
Keywords in English prolactin; risperidone; schizophrenia
Tags prolactin, risperidone, schizophrenia
Changed by Changed by: prof. MUDr. Eva Češková, CSc., učo 726. Changed: 23/6/2009 11:23.
Abstract
Patients with a first-episode of schizophrenia were clinical evaluated by PANSS and prolactinemia was assesed. Patients were treated with risperidon. Risperidon in average dose lower than 4 mg significantly improved both positive and negative symptoms. At the end of acute treatment the average elevation of PRL levels almost doubled the baseline value.There was a trend among responders to return to their initial values during long-term therapy.
Abstract (in English)
Patients with a first-episode of schizophrenia were clinical evaluated by PANSS and prolactinemia was assesed. Patients were treated with risperidon. Risperidon in average dose lower than 4 mg significantly improved both positive and negative symptoms. At the end of acute treatment the average elevation of PRL levels almost doubled the baseline value.There was a trend among responders to return to their initial values during long-term therapy.
PrintDisplayed: 19/4/2024 03:07